KRMD
KORU Medical Systems Inc.
Company Overview
| Mkt Cap | $190.03M | Price | $4.20 |
| Volume | 92.90K | Change | -1.06% |
| P/E Ratio | -31.3 | Open | $4.33 |
| Revenue | $33.6M | Prev Close | $4.24 |
| Net Income | $-6.1M | 52W Range | $1.86 - $6.61 |
| Div Yield | N/A | Target | $6.80 |
| Overall | 42 | Value | 40 |
| Quality | 68 | Technical | 18 |
No chart data available
About KORU Medical Systems Inc.
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 and FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
Latest News
REPRO-MED Systems Amends Credit Facility to Enhance Flexibility
B. Riley Securities Remains a Buy on REPRO-MED Systems (KRMD)
REPRO-MED Systems (KRMD) Gets a Hold from Piper Sandler
Canaccord Genuity Keeps Their Buy Rating on REPRO-MED Systems (KRMD)
Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX) and REPRO-MED Systems (KRMD)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KRMD | $4.20 | -1.1% | 92.90K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get KORU Medical Systems Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW